Cellebrite DI Ltd. (CLBT) exhibits 84.2% gross margins and 14.6% return on invested capital within Technology (Computer Software: Prepackaged Software), balanced against a 38.1x enterprise multiple and 4.8% implied options volatility.
Sustained 84.2% gross profitability converts into 14.0% operating margin and 14.6% ROIC, outpacing sector cost of capital.
ROIC: 14.6% // GM: 84.2%YoY revenue trajectory of +18.6% paired with 5.19% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +18.6% // FCF YLD: 5.19%Altman Z-Score of 4.95 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 4.95 // F-SCORE: 8/9Trading at 39.4x trailing P/E (33.1x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 39.4x // EV/EBITDA: 38.1xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $12.28 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Computer Software: Prepackaged Software require continuous execution to defend 16.5% net margins.
NET MARGIN: 16.5% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for CLBT & activate live FRED threshold breach alerts.